Join Cybin’s Psilocin Research Trial
We are seeking volunteers for a clinical trial evaluating a psilocin-based compound as a potential treatment for Major Depressive Disorder. Sponsored by Cybin, this double-blind, placebo-controlled study allows participants to remain on existing antidepressants. Follow-up continues for nearly a year, with the opportunity for repeat dosing in the open-label phase if symptoms return. If you are interested in the study, please fill out the pre-screening questionnaire. Upon completion, you will be directed to a team assessing your eligibility for the study.
